These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11293884

  • 21. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [Abstract] [Full Text] [Related]

  • 22. The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease.
    Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR.
    Ann N Y Acad Sci; 2006 Apr; 1068():543-56. PubMed ID: 16831950
    [Abstract] [Full Text] [Related]

  • 23. Sickle cell anaemia: is it a cause for secondary osteoporosis?
    Sadat-Ali M, Al Elq AH.
    West Afr J Med; 2007 Apr; 26(2):134-7. PubMed ID: 17939316
    [Abstract] [Full Text] [Related]

  • 24. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS, Serghini M, Ksontini I, Kedadi H, Ben Yaghléne L, Bougassas W, Dougui MH.
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [Abstract] [Full Text] [Related]

  • 25. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC, Huijberts MS, Schoon EJ, Geusens P, de Vries J, Menheere PP, van der Veer E, Wolffenbuttel BH, Stockbrugger RW, Dumitrescu B, Nieuwenhuijzen Kruseman AC.
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
    [Abstract] [Full Text] [Related]

  • 26. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
    Hamilton EJ, Rakic V, Davis WA, Chubb SA, Kamber N, Prince RL, Davis TM.
    Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
    [Abstract] [Full Text] [Related]

  • 27. Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy.
    Tobias JH, Sasi MR, Greenwood R, Probert CS.
    Aliment Pharmacol Ther; 2004 Nov 01; 20(9):951-7. PubMed ID: 15521842
    [Abstract] [Full Text] [Related]

  • 28. Increased serum bone sialoprotein concentrations in patients with Crohn's disease.
    Faust D, Menge F, Armbruster FP, Lembcke B, Stein J.
    Z Gastroenterol; 2003 Mar 01; 41(3):243-7. PubMed ID: 12664344
    [Abstract] [Full Text] [Related]

  • 29. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Mühlen A, Brabant G.
    Am J Gastroenterol; 1997 Jul 01; 92(7):1157-63. PubMed ID: 9219790
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of osteopenia and osteoporosis in a normal female Puerto Rican population.
    Haddock L.
    P R Health Sci J; 1997 Sep 01; 16(3):241-4. PubMed ID: 9431560
    [Abstract] [Full Text] [Related]

  • 31. A study on bone mineral density in patients with Crohn's disease.
    Oshima T, Taira S, Nonaka M, Hayama Y, Yagi K, Yukawa I, Koh M, Kondo M, Kawakami K, Kawai T, Miyaoka M, Sakai Y, Moriyasu F, Matauoka H, Yamamoto K.
    Hepatogastroenterology; 2008 Sep 01; 55(88):2116-20. PubMed ID: 19260488
    [Abstract] [Full Text] [Related]

  • 32. Bone mineral density changes within 11 months of renal transplantation in Iranian patients.
    Bayat N, Einollahi B, Pourfarzian V, Alishiri G, Nemati E, Bagheri N, Miri SM, Elizeii PK.
    Transplant Proc; 2007 May 01; 39(4):1039-43. PubMed ID: 17524886
    [Abstract] [Full Text] [Related]

  • 33. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
    Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD.
    Ann Hematol; 2010 Dec 01; 89(12):1207-13. PubMed ID: 20582415
    [Abstract] [Full Text] [Related]

  • 34. Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.
    Roblin X, Phelip JM, Genevois M, Ducros V, Bonaz B.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):797-804. PubMed ID: 17373918
    [Abstract] [Full Text] [Related]

  • 35. Osteopenia in survivors of Wilms tumor.
    Othman F, Guo CY, Webber C, Atkinson SA, Barr RD.
    Int J Oncol; 2002 Apr 01; 20(4):827-33. PubMed ID: 11894132
    [Abstract] [Full Text] [Related]

  • 36. [Developmental osteopenia: decrease of bone mineral density or systemic impairment?].
    Chlebna-Sokół D, Rusińska A, Szkudlarek J, Szkudlarek E.
    Pol Merkur Lekarski; 2000 Jul 01; 8(49):465-8. PubMed ID: 11070715
    [Abstract] [Full Text] [Related]

  • 37. Juvenile onset of Crohn's disease: a risk factor for reduced lumbar bone mass in premenopausal women.
    Mauro M, Armstrong D.
    Bone; 2007 May 01; 40(5):1290-3. PubMed ID: 17306637
    [Abstract] [Full Text] [Related]

  • 38. [High prevalence of osteoporosis in asymptomatic postmenopausal Mapuche women].
    Ponce L, Larenas G, Riedemann P.
    Rev Med Chil; 2002 Dec 01; 130(12):1365-72. PubMed ID: 12611237
    [Abstract] [Full Text] [Related]

  • 39. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M, Landowski P, Kamińska B, Góra-Gebka M, Popadiuk S, Renke J.
    Med Wieku Rozwoj; 2006 Dec 01; 10(2):445-51. PubMed ID: 16825715
    [Abstract] [Full Text] [Related]

  • 40. Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease.
    Bernstein M, Irwin S, Greenberg GR.
    Am J Gastroenterol; 2005 Sep 01; 100(9):2031-5. PubMed ID: 16128948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.